CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,238 | 18,712 | ||
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +2,557 | 30,000 | ||
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +2,363 | 32,363 | ||
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,083 | $21.77 | $24K | 31,280 |
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,001 | $21.77 | $22K | 30,279 |
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Share Option | +21,150 | 21,150 | ||
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Share Unit | +10,575 | 10,575 | ||
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −2,557 | 5,115 | ||
| 2025-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −2,363 | 7,087 | ||
| 2025-03-20 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +15,944 | $12.97 | $207K | 39,326 |
| 2025-03-20 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −15,944 | $23.11 | $368K | 23,382 |
| 2025-03-20 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −15,944 | 8,374 | ||
| 2025-03-19 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +8,879 | $12.97 | $115K | 32,261 |
| 2025-03-19 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −8,879 | $23.10 | $205K | 23,382 |
| 2025-03-19 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −8,879 | 24,318 | ||
| 2025-03-17 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +11,464 | $12.97 | $149K | 34,846 |
| 2025-03-17 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −11,464 | $23.10 | $265K | 23,382 |
| 2025-03-17 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −11,464 | 33,197 | ||
| 2025-03-16 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +872 | 23,830 | ||
| 2025-03-16 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes 10b5-1 | −448 | $22.61 | $10K | 23,382 |
Page 41 of 74 · 1,467 trades